This document outlines a proposed open randomized controlled clinical study to compare the efficacy of Agnimukha Churna and Kapitthasthak Churna in the clinical management of Grahani disease. The study will involve 60 subjects divided into two groups of 30 each, with one group receiving Agnimukha Churna and the other receiving Kapitthasthak Churna for 28 days. The primary objective is to evaluate the efficacy of Agnimukha Churna for Grahani, and the secondary objective is to compare the efficacy of the two treatments. The study will assess subjects over 4 follow-up periods using subjective and objective parameters to analyze treatment outcomes.